Holding XBI?
Track your performance easily

XBI Price & Analysis

XBI ETF Chart & Stats

Day’s Range― - ―
52-Week Range$68.31 - $92.60
Previous Close$70.3
VolumeN/A
Average Volume (3M)7.57M
AUM5.16B
NAV70.28
Expense Ratio0.35%
Holdings Count135
Beta1.04
Inception DateJan 31, 2006
<0.01 (―)
Shares Outstanding78,900,000
Standard Deviation0.08
10 Day Avg. Volume10,897,805
30 Day Avg. Volume7,574,165
Alpha-0.00858

XBI ETF FAQ

What was XBI’s price range in the past 12 months?
XBI lowest ETF price was $68.31 and its highest was $92.60 in the past 12 months.
    What is the AUM of XBI?
    As of Oct 17, 2023 The AUM of XBI is 5.16B.
      Is XBI overvalued?
      According to Wall Street analysts XBI’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does XBI pay dividends?
        XBI pays a Notavailable dividend of <$0.01 which represents an annual dividend yield of N/A. See more information on XBI dividends here
          How many shares outstanding does XBI have?
          XBI has 78,900,000 shares outstanding.
            Which hedge fund is a major shareholder of XBI?
            Among the largest hedge funds holding XBI’s share is Sivik Global Healthcare LLC. It holds XBI’s shares valued at 21M.

              XBI ETF Smart Score

              For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

              Top 10 Holdings

              Name
              Weight %
              Mirati Therapeutics
              2.23%
              Immunovant, Inc.
              1.67%
              Ionis Pharmaceuticals Inc.
              1.59%
              Amgen Inc
              1.56%
              Vertex Pharmaceuticals Inc.
              1.52%
              Apellis Pharmaceuticals
              1.50%
              Seagen Inc.
              1.49%
              United Therapeutics Corp.
              1.46%
              Neurocrine Biosciences
              1.44%
              Regeneron Pharmaceuticals
              1.43%
              Total15.88%

              ETF Description

              SPDR S&P BIOTECH ETF

              XBI tracks an equal-weighted index of US biotechnology stocks.
              Sector
              Sector
              Asset Class
              Equity
              Region
              North America
              Issuer
              SPDR
              Index Tracked
              S&P Biotechnology Select Industry
              Ticker Symbol
              XBI

              Popular ETFs

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis